Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Globus Medical Inc (GMED)

63.38   -1.06 (-1.64%) 01-27 06:04
Open: 64.56 Pre. Close: 64.44
High: 65 Low: 63.3
Volume: 209,436 Market Cap: 6,254M
Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders. Its spine product portfolio includes a range of implant and surgical approach options that can be used to treat degenerative, deformity, tumor, and trauma conditions affecting the spine from the occiput to the sacrum. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and regenerative biologic products, such as allografts and synthetic alternatives that are adjunctive treatments used in combination with stabilizing implant hardware. In addition, it provides motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous distraction devices, and interventional pain management solutions to treat vertebral compression fractures; imaging, navigation, and robotic assisted surgery technology solutions; and hip and knee joint solutions, as well as distributes human cell, tissue, and cellular and tissue based products. Further, the company offers expandable spacer products, which include RISE, RISE-L, CALIBER, CALIBER-L, ALTERA, ELSA, ELSA-ATP, SABLE, MAGNIFY, MAGNIFY-S, FORTIFY, and XPand; CREO thoracolumbar stabilization platform that offers instruments and implants for treating pathologies; CREO MIS and CREO MCS, options designed for less invasive surgery and minimal muscle disruption; CREO Derotation and CREO Rod Link Reducer systems, which help to streamline various derotation maneuvers for deformity correction; CREO Addition that provides a range of connectors; and CREO Fenestrated, a cement augmented pedicle screw system for patients with advanced stage tumors and limited life expectancy, as well as QUARTEX, an occipito-cervico-thoracic stabilization system. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 65.138 - 65.53 65.53 - 65.821
Low: 62.369 - 62.886 62.886 - 63.27
Close: 62.706 - 63.464 63.464 - 64.026

Technical analysis

as of: 2021-01-26 4:44:30 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 76.59     One year: 79.66
Support: Support1: 61.33    Support2: 51.03
Resistance: Resistance1: 65.58    Resistance2: 68.20
Pivot: 65.42
Moving Average: MA(5): 64.86     MA(20): 65.26
MA(100): 57.78     MA(250): 52.36
MACD: MACD(12,26): 0.52     Signal(9): 0.98
Stochastic oscillator: %K(14,3): 29.02     %D(3): 42.69
RSI: RSI(14): 45.86
52-week: High: 68.20  Low: 33.41  Change(%): 19.3
Average Vol(K): 3-Month: 59041  10-Days: 39525

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
GMED has closed above bottom band by 8.9%. Bollinger Bands are 25.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 20 Jan 2021
Globus Medical Inc. Class A (GMED) Soars 2.51% on January 20 - Equities.com

Tue, 19 Jan 2021
Globus Medical (GMED) US Spine Grows, Pricing Pressure Stays - Yahoo Finance

Mon, 11 Jan 2021
FY2020 EPS Estimates for Globus Medical, Inc. Raised by Analyst (NYSE:GMED) - MarketBeat

Fri, 08 Jan 2021
Globus Medical Inc. Class A (GMED) Soars 1.14% on January 08 - Equities.com

Fri, 08 Jan 2021
Credit Suisse Group Raises Globus Medical (NYSE:GMED) Price Target to $75.00 - MarketBeat

Fri, 01 Jan 2021
$234.25 Million in Sales Expected for Globus Medical, Inc. (NYSE:GMED) This Quarter - MarketBeat

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 76
Shares Float (M) 75
% Held by Insiders 0.88
% Held by Institutions 68.39
Shares Short (K) 1,400
Shares Short P. Month (K) 1,990

Stock Financials

EPS 0.930
EPS Est This Year 1.270
EPS Est Next Year 1.390
Book Value (p.s.) 14.360
Profit Margin 12.36
Operating Margin 13.92
Return on Assets (ttm) 4.5
Return on Equity (ttm) 6.9
Qtrly Rev. Growth 10.1
Gross Profit (p.s.) 7.941
Sales Per Share 10.064
EBITDA (p.s.) 2.188
Qtrly Earnings Growth 15.40
Operating Cash Flow (M) 173
Levered Free Cash Flow (M) 51

Stock Valuations

PE Ratio 68.15
PEG Ratio 3.47
Price to Book value 4.41
Price to Sales 6.30
Price to Cash Flow 27.94

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.